基于血液转录组的创伤后多器官衰竭/功能障碍综合征生物标志物预测模型的开发
本研究利用「炎症与损伤宿主反应研究」(Glue Grant)多中心队列中141例成人钝性创伤患者(58例MOF病例、83例非病例)的创伤后24小时内血沉棕黄层转录组数据和关联临床数据,应用LASSO和XGBoost算法筛选特征并构建MOF早期结局预测模型。LASSO模型纳入18个转录本(测试集AUROC 0.833 [95%CI 0.699-0.967]),XGBoost模型纳入41个转录本(测试集0.907 [0.816-0.998]),两模型重叠16个转录本(测试集0.836 [0.703-0.968])。生物标志物模型显著优于基于损伤严重度评分和性别的模型(如APACHEII+性别测试集0.493 [0.301-0.685];ISS+性别0.482 [0.293-0.670];NISS+性别0.525 [0.335-0.714])。作者认为创伤后立即从血样准确评估MOF有望改善临床决策,并可能有助于降低发病率、死亡率和医疗费用。
要点
- 在141例成人钝性创伤患者中,基于创伤后24小时内血沉棕黄层转录组的LASSO模型(18个转录本)预测MOF的测试集AUROC为0.833(95%CI 0.699-0.967)。
- XGBoost模型(41个转录本)预测MOF的测试集AUROC为0.907(95%CI 0.816-0.998),训练集为0.999(95%CI 0.997-1.000)。
- 两模型重叠的16个转录本在测试集中预测MOF的AUROC为0.836(95%CI 0.703-0.968)。
- 基于损伤严重度评分和性别的模型预测MOF的测试集AUROC分别为:APACHEII+性别0.493(95%CI 0.301-0.685)、ISS+性别0.482(95%CI 0.293-0.670)、NISS+性别0.525(95%CI 0.335-0.714)。
- 作者认为创伤后立即从血样准确评估MOF有望改善临床决策,并可能有助于降低发病率、死亡率和医疗费用。
适用人群与场景
- 成人(年龄≥16岁)钝性创伤患者,排除穿透性创伤,且具备创伤后≤24小时的血沉棕黄层样本。
研究设计与关键结果
- 研究类型:基于「炎症与损伤宿主反应研究」(Glue Grant)多中心队列的机器学习模型开发研究;样本量141例成人钝性创伤患者(58例MOF病例、83例非病例)。
- LASSO模型纳入18个转录本,预测MOF的AUROC:训练集0.938(95%CI 0.890-0.987),测试集0.833(95%CI 0.699-0.967)。
- XGBoost模型纳入41个转录本,预测MOF的AUROC:训练集0.999(95%CI 0.997-1.000),测试集0.907(95%CI 0.816-0.998)。
- 两模型重叠16个转录本,预测MOF的AUROC:训练集0.935(95%CI 0.884-0.985),测试集0.836(95%CI 0.703-0.968)。
- 基于损伤严重度评分和性别的模型预测MOF的AUROC:APACHEII+性别训练集0.649(95%CI 0.537-0.762)、测试集0.493(95%CI 0.301-0.685);ISS+性别训练集0.630(95%CI 0.516-0.744)、测试集0.482(95%CI 0.293-0.670);NISS+性别训练集0.651(95%CI 0.540-0.763)、测试集0.525(95%CI 0.335-0.714)。
证据类型、等级与局限
- 证据类型:基于多中心队列的机器学习预测模型开发研究;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,创伤后立即从血样准确评估MOF有望改善临床决策,并可能有助于降低发病率、死亡率和医疗费用。
- 作者认为,理解对MOF预测重要的转录本所涉及的分子机制可能最终有助于开发新干预措施。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Multiple organ failure/dysfunction syndrome (MOF/MODS) is a major cause of mortality and morbidity among severe trauma patients. Current clinical practices entail monitoring physiological measurements and applying clinical score systems to diagnose its onset. Instead, we aimed to develop an early prediction model for MOF outcome evaluated soon after traumatic injury by performing machine learning analysis of genome-wide transcriptome data from blood samples drawn within 24 h of traumatic injury. We then compared its performance to baseline injury severity scores and detection of infections.
METHODS: Buffy coat transcriptome and linked clinical datasets from blunt trauma patients from the Inflammation and the Host Response to Injury Study ("Glue Grant") multi-center cohort were used. According to the inclusion/exclusion criteria, 141 adult (age ≥ 16 years old) blunt trauma patients (excluding penetrating) with early buffy coat (≤ 24 h since trauma injury) samples were analyzed, with 58 MOF-cases and 83 non-cases. We applied the Least Absolute Shrinkage and Selection Operator (LASSO) and eXtreme Gradient Boosting (XGBoost) algorithms to select features and develop models for MOF early outcome prediction.
RESULTS: The LASSO model included 18 transcripts (AUROC [95% CI]: 0.938 [0.890-0.987] (training) and 0.833 [0.699-0.967] (test)), and the XGBoost model included 41 transcripts (0.999 [0.997-1.000] (training) and 0.907 [0.816-0.998] (test)). There were 16 overlapping transcripts comparing the two panels (0.935 [0.884-0.985] (training) and 0.836 [0.703-0.968] (test)). The biomarker models notably outperformed models based on injury severity scores and sex, which we found to be significantly associated with MOF (APACHEII + sex-0.649 [0.537-0.762] (training) and 0.493 [0.301-0.685] (test); ISS + sex-0.630 [0.516-0.744] (training) and 0.482 [0.293-0.670] (test); NISS + sex-0.651 [0.540-0.763] (training) and 0.525 [0.335-0.714] (test)).
CONCLUSIONS: The accurate assessment of MOF from blood samples immediately after trauma is expected to aid in improving clinical decision-making and may contribute to reduced morbidity, mortality and healthcare costs. Moreover, understanding the molecular mechanisms involving the transcripts identified as important for MOF prediction may eventually aid in developing novel interventions.
参考来源
- Duran I, Banerjee A, Flaherty PJ, et al. Development of a biomarker prediction model for post-trauma multiple organ failure/dysfunction syndrome based on the blood transcriptome. Ann Intensive Care. 2024. PMID: 39198331. doi:10.1186/s13613-024-01364-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。